▷ AbbVie Dividends 【Calendar 2024】

Upcoming AbbVie dividend

Change(%)

+5.81%

Increase

Next payment 1.64$

Next payment date Feb 14, 2025

Last payment 1.55$

Last payment date Nov 15, 2024

00 D 00 H 00 M 00 S

Ex-Dividend: 1/15/25

Confirmed

When are the upcoming AbbVie dividends in 2024?

▶

February 14, 2025 is the date chosen by AbbVie for the payment of dividends, which will be 1,64 dollars per share.

What is the last day to buy AbbVie stocks and get dividends?

▶

Remember, investors in AbbVie (ABBV): January 14, 2025 is your last chance to buy and qualify for dividends, keeping in mind that the Record Date is January 15, 2025, when your ownership is verified.

Last AbbVie dividend

▶

The dividend from AbbVie, 1.55 dollars, was credited on November 15, 2024, following the ex-dividend on October 15, 2024.

Dividend policy of AbbVie

▶

As almost all North American companies do, AbbVie divides the annual dividend payment into four parts, depositing it quarterly in February, May, August and November.

However, its payout is approximately 80% and the dividend yield is around 4%.

Payout Ratio AbbVie Dividends

AbbVie paid 21% of its net income in the last fiscal period as dividends.

AbbVie's earnings (55,532,998,656.00$) are sufficient to cover the dividend payment. This payment represents 21% of the total net profit of ABBV.

Dividend payout ratio Payout Ratio

Dividend calendar of AbbVie

These are the most important events of the AbbVie calendar in 2024:

Event	Day
Last trading date	January 14, 2025
Ex-Dividend (Ex-Date)	January 15, 2025
Record date	January 15, 2025
Date of payment	February 14, 2025

Data confirmed by the company AbbVie (ABBV).

Confirmed Source

Dividend yield of AbbVie vs. the sector

AbbVie's dividend yield (3.79%) is below the sector average (4.36%).

Comparison with industry average

AbbVie's dividend yield is between the top 25% (6.50%) and top 75% (3.22%) of the sector.

Evaluation with respect to competence.

Information about AbbVie

Full name AbbVie Inc.

Ticker ABBV

Sector Health Care

Industry Drug Manufacturers - General

Market Capitalization 308.46B $

Number of Employees 50,000

Description of the company

AbbVie is a company involved in the pharmaceutical industry, designing, manufacturing and marketing drugs and solutions for the treatment of a wide variety of diseases.

It was founded from the fragmentation of Abbot Laboratories in 2013, establishing its headquarters in Illinois, USA, has sales in more than 175 countries, with subsidiaries in Germany, Bermuda and The Bahamas.

Its products cover the treatment of more than 60 pathologies, including immunology, oncology, neuroscience, ophthalmology, esthetics and virology, with research and development operations in 20 countries and more than 50,000 employees distributed among its various factories.

Its operations emphasize research and personalization of therapies, tailored to the needs of each patient, investing in technologies such as precision medicine, genetics, data convergence and genomics.